-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2023 to Q2 2025.
- Inhibrx Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$27.4M, a 83% increase year-over-year.
- Inhibrx Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$167M.
- Inhibrx Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$331M, a 51.2% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)